The FDA approved the first PrEP drug, Truvada, in 2012. AP Photo/Jeff Chiu – but the latest challenge to the Affordable Care Act puts this benefit atrisk Paul Shafer, Boston University and Kristefer Stojanovski, Tulane University Since the start of the HIV epidemic in 1981, over 700,000 Americans